((R)-6-((S)-2-(tert-butylammonio)-1-hydroxyethyl)-2-hydroxy-2-isobutyl-4H-benzo[d][1,3,2]dioxaborinin-2-uide))

ID: ALA3393402

PubChem CID: 118725500

Max Phase: Preclinical

Molecular Formula: C17H30BNO4

Molecular Weight: 323.24

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)C[B-]1(O)OCc2cc([C@@H](O)C[NH2+]C(C)(C)C)ccc2O1

Standard InChI:  InChI=1S/C17H29BNO4/c1-12(2)9-18(21)22-11-14-8-13(6-7-16(14)23-18)15(20)10-19-17(3,4)5/h6-8,12,15,19-21H,9-11H2,1-5H3/q-1/p+1/t15-,18?/m0/s1

Standard InChI Key:  WZFYFHBOHCIEOC-BUSXIPJBSA-O

Molfile:  

     RDKit          2D

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2964    1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5121    1.4924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8109    0.7403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2964   -1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2109    0.7445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9122    1.4966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964   -1.4973    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964    1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9141    2.6966    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929    0.7486    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8513    1.3383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8491    0.1384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8090   -0.4597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929   -0.7486    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    3.6170   -0.1233    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5565   -2.2286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2571   -2.9796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2569   -4.1796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2177   -2.3798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  1  1  0
  5  9  1  0
  6  8  1  0
  7  5  1  0
  8  4  2  0
  9 10  1  0
 10  3  1  0
 11  4  1  0
 12  1  1  0
 10 13  1  6
 14 12  1  0
 15  7  1  0
 16  7  1  0
 17  7  1  0
  6  3  2  0
 11 18  1  0
 14 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
M  CHG  2   5   1  18  -1
M  END

Alternative Forms

  1. Parent:

    ALA3393402

    ---

Associated Targets(non-human)

Adrb2 Beta-2 adrenergic receptor (1382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 323.24Molecular Weight (Monoisotopic): 323.2268AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Soriano-Ursúa MA, Arias-Montaño JA, Correa-Basurto J, Hernández-Martínez CF, López-Cabrera Y, Castillo-Hernández MC, Padilla-Martínez II, Trujillo-Ferrara JG..  (2015)  Insights on the role of boron containing moieties in the design of new potent and efficient agonists targeting the β2 adrenoceptor.,  25  (4): [PMID:25592716] [10.1016/j.bmcl.2014.12.077]

Source